Literature DB >> 14872056

Idebenone treatment in Friedreich patients: one-year-long randomized placebo-controlled trial.

Pierre Rustin, Damien Bonnet, Agnès Rötig, Arnold Munnich, Daniel Sidi.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14872056     DOI: 10.1212/wnl.62.3.524

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  14 in total

Review 1.  Milestones in Friedreich ataxia: more than a century and still learning.

Authors:  Agessandro Abrahão; José Luiz Pedroso; Pedro Braga-Neto; Edson Bor-Seng-Shu; Patricia de Carvalho Aguiar; Orlando Graziani Povoas Barsottini
Journal:  Neurogenetics       Date:  2015-02-08       Impact factor: 2.660

Review 2.  Drug development for rare mitochondrial disorders.

Authors:  Orest Hurko
Journal:  Neurotherapeutics       Date:  2013-04       Impact factor: 7.620

3.  Combined therapy with idebenone and deferiprone in patients with Friedreich's ataxia.

Authors:  Daniel Velasco-Sánchez; Asuncion Aracil; Raquel Montero; Ana Mas; Lorenzo Jiménez; Mar O'Callaghan; Maria Tondo; Antoni Capdevila; Josep Blanch; Rafael Artuch; Mercedes Pineda
Journal:  Cerebellum       Date:  2011-03       Impact factor: 3.847

4.  Rational selection of small molecules that increase transcription through the GAA repeats found in Friedreich's ataxia.

Authors:  LaKechia Grant; Jun Sun; Hongzhi Xu; S H Subramony; Jonathan B Chaires; Michael D Hebert
Journal:  FEBS Lett       Date:  2006-09-15       Impact factor: 4.124

Review 5.  Mitochondrial optic neuropathies - disease mechanisms and therapeutic strategies.

Authors:  Patrick Yu-Wai-Man; Philip G Griffiths; Patrick F Chinnery
Journal:  Prog Retin Eye Res       Date:  2010-11-26       Impact factor: 21.198

Review 6.  Current Drug Repurposing Strategies for Rare Neurodegenerative Disorders.

Authors:  Sweta Shah; Marc Marie Dooms; Sofia Amaral-Garcia; Mariana Igoillo-Esteve
Journal:  Front Pharmacol       Date:  2021-12-21       Impact factor: 5.810

Review 7.  Idebenone: an emerging therapy for Friedreich ataxia.

Authors:  Thomas Meier; Gunnar Buyse
Journal:  J Neurol       Date:  2009-03       Impact factor: 4.849

8.  Modification of respiratory-chain enzyme activities in brown adipose tissue mitochondria by idebenone (hydroxydecyl-ubiquinone).

Authors:  H Rauchová; Z Drahota; C Bergamini; R Fato; G Lenaz
Journal:  J Bioenerg Biomembr       Date:  2008-03-27       Impact factor: 2.945

Review 9.  Pharmacotherapy for Friedreich ataxia.

Authors:  Amy Y Tsou; Lisa S Friedman; Robert B Wilson; David R Lynch
Journal:  CNS Drugs       Date:  2009       Impact factor: 5.749

Review 10.  Liver disease in mitochondrial disorders.

Authors:  Way S Lee; Ronald J Sokol
Journal:  Semin Liver Dis       Date:  2007-08       Impact factor: 6.115

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.